The WNT/β-catenin signalling pathway has recently gained attention for its effects on TNBC, despite absence of recurrent β-catenin mutations or classical genetic lesions associated with this pathway’s overactivation, such as APC loss in colorectal cancer [46]. This evidence concerns the gene APC and colorectal cancer.